P&G CEO granted 22,787 stock options at $146.67
P&G’s CEO received a 22,787-share stock option grant at a $146.67 exercise price, adding to his existing direct and indirect equity holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
PROCTER & GAMBLE Co (PG) reported that Chairman, President and CEO Shailesh Jejurikar received a grant of stock options on September 15, 2026. The award covers 22,787 options to acquire an equal number of shares of common stock at an exercise price of $146.67 per share, expiring on September 15, 2036.
After this grant, he holds 22,787 stock options directly. His reported common stock positions total 39,325.9973 shares held directly and additional indirect holdings through a retirement plan and two trusts.
Insider Trade Summary
Grant/Award: 22,787 shares
Grant/Award
1 txn
Insider
Jejurikar Shailesh
Role
Chairman, President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 22,787 | $0.00 | $0.00 |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 22,787 contracts (Direct);
Common Stock — 39,325.9973 shares (Direct);
Common Stock — 3,741.7415 shares (Indirect, By Retirement Plan Trustee);
Common Stock — 19,757 shares (Indirect, Sankhya S Jejurikar Revocable Trust);
Common Stock — 35,836 shares (Indirect, Shailesh Jejurikar Trust)
Key Figures
Stock options granted: 22,787 options
Exercise price: $146.67 per share
Option expiration date: September 15, 2036
+5 more
8 metrics
Stock options granted
22,787 options
Grant to CEO on September 15, 2026
Exercise price
$146.67 per share
Exercise price of stock option grant reported for September 15, 2026
Option expiration date
September 15, 2036
Expiration date of granted stock options
Option exercisability date
September 14, 2029
Date options become exercisable
Common stock held directly
39,325.9973 shares
Direct PG common stock holdings after September 15, 2026 transactions
Common stock via Retirement Plan Trustee
3,741.7415 shares
Indirect PG shares held by Retirement Plan Trustee
Common stock via Sankhya S Jejurikar Revocable Trust
19,757 shares
Indirect PG shares held by revocable trust
Common stock via Shailesh Jejurikar Trust
35,836 shares
Indirect PG shares held by Shailesh Jejurikar Trust
Key Terms
Stock Option (Right to Buy), Exercise price, Expiration date, Retirement Plan Trustee, +1 more
5 terms
Stock Option (Right to Buy) financial
"The security title is listed as Stock Option (Right to Buy)"
Exercise price financial
"The conversion or exercise price is reported for the option grant"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Expiration date financial
"The option award includes an expiration date of 2036-09-15"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Retirement Plan Trustee financial
"Indirect ownership is described as By Retirement Plan Trustee"
Revocable Trust financial
"Indirect ownership is listed as Sankhya S Jejurikar Revocable Trust"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PG’s CEO Shailesh Jejurikar receive in this Form 4 filing?
He received a grant of 22,787 stock options on September 15, 2026, each option giving the right to buy one share of PROCTER & GAMBLE Co common stock at an exercise price of $146.67 per share, expiring on September 15, 2036.
What is the exercise price and term of the new PG stock options?
The stock options have an exercise price of $146.67 per share. They are scheduled to become exercisable on September 14, 2029 and carry an expiration date of September 15, 2036, after which any unexercised options will lapse.
How many PG stock options does the CEO hold after this transaction?
Following this award, Shailesh Jejurikar is reported as holding 22,787 stock options directly. These options each relate to one share of PROCTER & GAMBLE Co common stock, according to the filing’s derivative security disclosure.
What are the CEO’s direct common stock holdings in PG after the reported transactions?
His direct holdings in PROCTER & GAMBLE Co common stock are reported as 39,325.9973 shares following the transactions dated September 15, 2026. This figure reflects only shares held directly in his name.
Was this PG Form 4 transaction made under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirming a trading plan. No footnote language is provided indicating that the reported stock option grant or holdings were effected under a Rule 10b5-1 or similar pre-arranged plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
